(Q51160856)

English

A comparison of antibody responses to commercial equine influenza vaccines following annual booster vaccination of National Hunt horses - a randomised blind study.

scientific article published on 17 March 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/21419776

A comparison of antibody responses to commercial equine influenza vaccines following annual booster vaccination of National Hunt horses - a randomised blind study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/21419776

1 reference

based on heuristic

inferred from title

influenza vaccine

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/21419776

author name string

Sarah Gildea

1

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/21419776

Sean Arkins

2

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/21419776

Ann Cullinane

4

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/21419776

language of work or name

0 references

publication date

17 March 2011

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/21419776

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/21419776

29

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/21419776

22

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/21419776

3917-3922

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/21419776

Duration of protective efficacy of equine influenza immunostimulating complex/tetanus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.003

7 January 2021

Immunity to equine influenza: relationship of vaccine-induced antibody in young Thoroughbred racehorses to protection against field infection with influenza A/equine-2 viruses (H3N8)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.003

7 January 2021

Are equine 1 influenza viruses still present in horses?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.003

7 January 2021

Equine influenza - surveillance and control

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.003

7 January 2021

Evidence supporting the inclusion of strains from each of the two co-circulating lineages of H3N8 equine influenza virus in vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.003

7 January 2021

Area under the curve calculations as a tool to compare the efficacy of equine influenza vaccines--a retrospective analysis of three independent field trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.003

7 January 2021

Risk factors for equine influenza serum antibody titres in young thoroughbred racehorses given an inactivated vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.003

7 January 2021

Duration of circulating antibody and immunity following infection with equine influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.003

7 January 2021

A comparative antibody study of the potential susceptibility of Thoroughbred and non-Thoroughbred horse populations in Ireland to equine influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.003

7 January 2021

Efficacy of a canarypox-vectored recombinant vaccine expressing the hemagglutinin gene of equine influenza H3N8 virus in the protection of ponies from viral challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.003

7 January 2021

Antigenicity and immunogenicity of equine influenza vaccines containing a Carbomer adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.003

7 January 2021

An updated equine influenza vaccine and an equine influenza-herpesvirus combination vaccine containing an immunostim adjuvant provoke equal antibody levels in young foals throughout the primary vaccination course

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.003

7 January 2021

Protection, systemic IFNgamma, and antibody responses induced by an ISCOM-based vaccine against a recent equine influenza virus in its natural host

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.003

7 January 2021

A randomized, double blind study in young healthy adults comparing cell mediated and humoral immune responses induced by influenza ISCOM? vaccines and conventional vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.003

7 January 2021

Efficacy of a recombinant equine influenza vaccine against challenge with an American lineage H3N8 influenza virus responsible for the 2003 outbreak in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.003

7 January 2021

Antibody and IFN-gamma responses induced by a recombinant canarypox vaccine and challenge infection with equine influenza virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.003

7 January 2021

Field Studies on Equine Influenza Vaccination Regimes in Thoroughbred Foals and Yearlings

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.003

7 January 2021

Optimising vaccination strategies in equine influenza

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.003

7 January 2021

Age and long-term protective immunity in dogs and cats

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.003

7 January 2021

Identifiers

10.1016/J.VACCINE.2011.03.003

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/21419776

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/21419776

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51160856&oldid=1531255412"